费妖
Lv1
30 积分
2022-07-27 加入
-
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes
24天前
已完结
-
Association of accelerometer-measured physical activity and its change with progression to chronic kidney disease in adults with type 2 diabetes and overweight/obesity
1个月前
已完结
-
Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial
3个月前
已完结
-
1型糖尿病自我管理教育与支持专家共识(2023版)
8个月前
已完结
-
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial
9个月前
已完结
-
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
9个月前
已完结
-
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
11个月前
已完结
-
Current diagnostic criteria identify risk for type 2 diabetes too late
1年前
已完结
-
Preventing Type 2 Diabetes With Vitamin D: Therapy Versus Supplementation
1年前
已完结
-
Contemporary medical, device, and surgical therapies for obesity in adults
1年前
已完结